SNORA71A targeted LEP participated in Jak-STAT signaling pathway, nonalcoholic fatty liver disease (NAFLD), and cytokine-cytokine receptor interaction. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.